Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies

PubMed(2023)10.1142/9789811286421_0022Source: DataRank Database

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies is a research paper published in PubMed (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Kevin A. Chen ORCID,Samantha Beville,Timothy J. Stuhlmiller ORCID,Matthew E. Berginski ORCID,Denis O. Okumu ORCID

Live enrichment

PubMed:38160286 PMC:PMC11413988 OpenAlex:https://openalex.org/W4389858823

NIDDK NIH HHS

Grant: U24 DK116204

NCI NIH HHS

Grant: U01 CA238475

NCI NIH HHS

Grant: R01 CA233811

NCI NIH HHS

Grant: P50 CA257911

NCI NIH HHS

Grant: R01 CA288145

NCI NIH HHS

Grant: U01 CA274298

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by-nc

http://dx.doi.org/10.1142/9789811286421_0022

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38160286

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11413988

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11413988/pdf/nihms-2007337.pdf

Fields of Study

Cancer-related Molecular PathwaysProtein Degradation and InhibitorsHER2/EGFR in Cancer Research

MeSH Terms

Antineoplastic AgentsHumansMelanomaComputational BiologyCell Line, TumorProtein Kinase InhibitorsTriple Negative Breast Neoplasms

Keywords

KinomeCancer cell linesSensitivity (control systems)Cancer researchKinaseCancerMedicineCancer cellBiologyInternal medicineCell biology

Sustainable Development Goals

SDG 0: Zero hunger

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies

FAIR Checklist

Authors (10)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)